#news #biotech Merck writes off big bet on CETP drug anacetrapib

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Merck writes off big bet on CETP drug anacetrapib .Merck, the last big firm standing in the once-hyped CETP field, has opted against filing for approval of anacetrapib. The Big Pharma reached the decision after going over a mixed set of data from its big bet on a phase 3 program.

from FierceBiotech: Biotech http://ift.tt/2hDcKvs